Neuroleptic malignant syndrome while on tiapride treatment

Clin Neuropharmacol. 1996 Dec;19(6):539-40.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Dyskinesia Agents / adverse effects*
  • Anti-Dyskinesia Agents / therapeutic use
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Neuroleptic Malignant Syndrome / etiology*
  • Tiapamil Hydrochloride / adverse effects*
  • Tiapamil Hydrochloride / therapeutic use

Substances

  • Anti-Dyskinesia Agents
  • Antipsychotic Agents
  • Tiapamil Hydrochloride